Class Action Participation

Investor Firms Urge Baxter Shareholders to Act Before Dec. 15 in Novum IQ Pump Securities Case

Plaintiffs contend Baxter concealed serious defects in its Novum IQ infusion pump that later drew an FDA Class I recall.